Results 211 to 220 of about 129,018 (360)

Making high‐quality measures available in diverse contexts—The psychometric properties of the Revised Child Anxiety and Depression Scale in a Norwegian sample

open access: yesInternational Journal of Methods in Psychiatric Research, Volume 31, Issue 4, December 2022., 2022
Abstract Objectives Recent initiatives have recommended the Revised Child Anxiety and Depression Scale (RCADS) for use in research and as patient‐reported outcome in health care globally. We aimed to investigate, for the first time, whether the psychometric properties of the anxiety and depression youth self‐report measures, RCADS‐47 and RCADS‐25 ...
Carina Lisøy   +5 more
wiley   +1 more source

Myotonic dystrophy type 1: A comparison between the adult‐ and late‐onset subtype

open access: yesMuscle &Nerve, Volume 67, Issue 2, Page 130-137, February 2023., 2023
Abstract Introduction/Aims Although the extent of muscle weakness and organ complications has not been well studied in patients with late‐onset myotonic dystrophy type 1 (DM1), adult‐onset DM1 is associated with severe muscle involvement and possible life‐threatening cardiac and respiratory complications.
Isis B.T. Joosten   +8 more
wiley   +1 more source

Oral edaravone demonstrated a favorable safety profile in patients with amyotrophic lateral sclerosis after 48 weeks of treatment

open access: yesMuscle &Nerve, Volume 67, Issue 2, Page 124-129, February 2023., 2023
Abstract Introduction/Aims An intravenous (IV) formulation of edaravone has been shown to slow the rate of physical functional decline in amyotrophic lateral sclerosis (ALS). An oral suspension formulation of edaravone was recently approved by the United States Food and Drug Administration for use in patients with ALS.
Angela Genge   +16 more
wiley   +1 more source

Severe relapse after cessation of immunosuppressive therapy in a patient with co‐occurrence of neuromyelitis optica spectrum disorder and Sjögren's syndrome: A case report

open access: yesIbrain, EarlyView.
We report a girl with a diagnosis of “neuromyelitis optica spectrum disorder comorbid Sjogren's syndrome” whose condition showed significant improvement after treatment with corticosteroids and immunosuppressive drugs (prednisolone, hydroxychloroquine, and mycophenolate mofetil).
Man‐Min Zhu   +3 more
wiley   +1 more source

Experiences of health management among people at high risk of stroke in China: A qualitative study

open access: yesNursing Open, Volume 10, Issue 2, Page 613-622, February 2023., 2023
Abstract Background Effective health management of people at high risk of stroke in China is challenging. Aim To explore and identify the experiences of health management among people at high risk of stroke in order to provide a foundation for a targeted health management strategy for this special group. Design A qualitative, descriptive study based on
Lina Guo   +7 more
wiley   +1 more source

Salvage Surgery Following Remarkable Tumor Shrinkage With Enfortumab Vedotin in Advanced Urothelial Carcinoma

open access: yesIJU Case Reports, EarlyView.
ABSTRACT Introduction We report a case in which enfortumab vedotin (EV) therapy was administered as a third‐line treatment for locally advanced bladder cancer (bc), enabling successful radical resection. Case Presentation This report describes the case of a 69‐year‐old male patient with locally advanced bc and pelvic lymph node (LN) metastases.
Keita Minami   +4 more
wiley   +1 more source

Construction of haemodialysis nursing‐sensitive quality indicators based on Donabedian theory: A Delphi method study

open access: yesNursing Open, Volume 10, Issue 2, Page 807-816, February 2023., 2023
Abstract Aims To establish a sensitive, scientific and practical evaluation system for haemodialysis nursing and to provide a reference for the evaluation of haemodialysis nursing quality. Design Through a literature review and Delphi method. Method According to the literature review, a preliminary nursing‐sensitive quality indicators for haemodialysis
Lin Chen   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy